Battling Deadly Diseases--13 Antibiotic Makers

Image via Wikipedia

Top Antibiotic Makers:

Trius Therapeutics--(TSRX)
Forest Labs--(FRX)
Optimer Pharmaceuticals--(OPTR)

These stocks haven't necessarily done extremely well this year, but the high cost of Clinical Trials leads to debt.  Once the clinical trials are approved and these antibiotics go on the market these should have noticeable gains.  I think these could have potential to invest in the long term futures.

Another company of note is SIGA Technologies (SIGA).  SIGA makes bioweapons vaccines for the government and recently announced a government contract for small pox treatment.  From Marketwatch:  SIGA soars on government contract. 
 
Hope In The Grim Fight Against Drug-Resistant Germs

Forest Labs Antibiotic Seems Effective FDA Notes Revealed

Image via Wikipedia FDA staff back safety, efficacy of ceftaroline

* Advisory panel to review drug on Tuesday
* Forest shares up 5.4 pct in afternoon
* Nearly $361 million in ceftaroline sales seen in 2014 (Revises first sentence, adds analyst comment, updates shares)
By Lisa Richwine

WASHINGTON, Sept 2 (Reuters) - A Forest Laboratories Inc (FRX.N) antibiotic appears effective with risks similar to current options, U.S. drug reviewers said in an analysis that raised hopes for the medicine's approval.

Shares of Forest, which needs new medicines to offset looming patent expirations on its major drugs, were up $1.49 or 5.4 percent at $29.14 on the New York Stock Exchange after the Food and Drug Administration released its preliminary review on Thursday.

Analysts expect nearly $361 million in sales in 2014 for the potential new antibiotic called ceftaroline, according to Thomson Reuters forecasts.